You do realise that by middle 2016 all indications are that...

You do realise that by middle 2016 all indications are that Amgen are releasing Repatha in a wearable by West?

And CV IS the big prize. LDL/cholesterol is the near term but long term it is all about CV.

It will be very interesting if Amgen shelve their West Smartdose program and throw it in a UNS wearable. I cant see it happening for a long while. More than likely other Amgen drugs will find their way into UNS wearables before Repatha. In fact Unifill and Lisa is surely a winning combination from a functionality and cost perspective for many pharmas. I am very disappointed Lisa and Unifill have not made a dent in the disposable AID market